Nektar Therapeutics
NKTR
$75.06
$2.853.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 245.75M | 270.21M | 175.90M | 218.63M | 255.23M |
| Total Receivables | 1.78M | 1.29M | 1.35M | 1.71M | 1.61M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.20M | 2.36M | 1.73M | 2.21M | 2.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.54M | 7.50M | 7.58M | 7.36M | 1.95M |
| Total Current Assets | 266.27M | 281.36M | 186.57M | 229.91M | 261.29M |
|
|
|||||
| Total Current Assets | 266.27M | 281.36M | 186.57M | 229.91M | 261.29M |
| Net Property, Plant & Equipment | 5.00M | 10.00M | 10.57M | 11.16M | 11.82M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.65M | 5.16M | 5.02M | 5.39M | 4.65M |
| Total Assets | 280.41M | 301.35M | 207.53M | 256.24M | 303.85M |
|
|
|||||
| Total Accounts Payable | 10.77M | 15.56M | 14.28M | 17.83M | 11.56M |
| Total Accrued Expenses | 19.64M | 25.45M | 31.82M | 28.43M | 27.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.50M | 22.18M | 22.01M | 21.84M | 19.87M |
| Total Finance Division Other Current Liabilities | 2.63M | 3.15M | 3.28M | 2.83M | 2.77M |
| Total Other Current Liabilities | 2.63M | 3.15M | 3.28M | 2.83M | 2.77M |
| Total Current Liabilities | 53.54M | 66.34M | 71.39M | 70.93M | 61.40M |
|
|
|||||
| Total Current Liabilities | 53.54M | 66.34M | 71.39M | 70.93M | 61.40M |
| Long-Term Debt | 63.16M | 75.16M | 80.57M | 86.32M | 91.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 65.26M | 69.73M | 74.15M | 78.50M | 82.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.63M | 5.03M | 5.64M | 6.76M | 7.24M |
| Total Liabilities | 190.57M | 216.26M | 231.75M | 242.50M | 243.11M |
|
|
|||||
| Common Stock & APIC | 3.85B | 3.81B | 3.67B | 3.66B | 3.66B |
| Retained Earnings | -3.76B | -3.72B | -3.69B | -3.65B | -3.60B |
| Treasury Stock & Other | 17.00K | 56.00K | -3.01M | -2.96M | -2.94M |
| Total Common Equity | 89.83M | 85.09M | -24.21M | 13.74M | 60.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 89.83M | 85.09M | -24.21M | 13.74M | 60.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 89.83M | 85.09M | -24.21M | 13.74M | 60.74M |
|
|
|||||